✨ Medicines Distribution Consents




12 JULY

NEW ZEALAND GAZETTE

1685

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product:
Apo-Cal
Active Ingredient(s):
Calcium carbonate 625mg
Dosage Form:
Tablet
New Zealand Sponsor:
Apotex NZ Limited
Manufacturer(s):
Apotex Inc, Weston, Ontario, Canada

Product:
Apo-Cal
Active Ingredient(s):
Calcium carbonate 1,250mg
Dosage Form:
Tablet
New Zealand Sponsor:
Apotex NZ Limited
Manufacturer(s):
Apotex Inc, Weston, Ontario, Canada

Product:
Estelle-35 ED
Active Ingredient(s):
Cyproterone acetate 2mg
Ethinyloestradiol 0.035mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Douglas Pharmaceuticals Limited
Manufacturer(s):
Douglas Manufacturing, div. Douglas Pharmaceuticals Limited, Lincoln, Auckland

Product:
Estelle-35
Active Ingredient(s):
Cyproterone acetate 2mg
Ethinyloestradiol 0.035mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Douglas Pharmaceuticals Limited
Manufacturer(s):
Douglas Manufacturing, div. Douglas Pharmaceuticals Limited, Lincoln, Auckland

Product:
Focus Lens Fresh
Active Ingredient(s):
Povidone 50mg/mL
Dosage Form:
Eye drops, solution
New Zealand Sponsor:
Ciba Vision New Zealand
Manufacturer(s):
Laboratoires Ciba Vision Faure, La Lombardiere Industrial Zone, Annonay Cedex, France

Product:
Zodac
Active Ingredient(s):
Cetirizine hydrochloride 10mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Douglas Pharmaceuticals Limited
Manufacturer(s):
Leciva as, Praha, Czech Republic

Dated this 3rd day of July 2001.

G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).

go4701

Consent to the Distribution of Changed Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:

Schedule

Product:
Botox
Active Ingredient(s):
Botulinum A toxin 100U
Dosage Form:
Powder for injection
New Zealand Sponsor:
Allergan New Zealand Limited
Manufacturer(s):
Allergan Berkeley, Berkeley, California, United States of America
Allergan Pharmaceuticals (Ireland) Limited, Westport, County Mayo, Eire
Biological Laboratories Europe, Carrentrila, Ballina, County Mayo, Eire
Northview Pacific Labs, Berkeley, California, United States of America
Pharmacia (formerly Adria SP Inc), Alburquerque, New Mexico, United States of America

Product:
Camptosar
Active Ingredient(s):
Irinotecan hydrochloride 20mg/mL
Dosage Form:
Solution for injection
New Zealand Sponsor:
Pharmacia Limited Company trading as Pharmacia
Manufacturer(s):
Pharmacia & Upjohn Company, Kalamazoo, Michigan, United States of America



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2001, No 71


Gazette.govt.nz PDF NZ Gazette 2001, No 71





✨ LLM interpretation of page content

πŸ₯ Consent to the Distribution of New Medicines (continued from previous page)

πŸ₯ Health & Social Welfare
3 July 2001
Medicines, Distribution, Apo-Cal, Estelle-35 ED, Estelle-35, Focus Lens Fresh, Zodac
  • G. R. Boyd, Chief Advisor, Safety and Regulation

πŸ₯ Consent to the Distribution of Changed Medicines

πŸ₯ Health & Social Welfare
Medicines, Distribution, Botox, Camptosar